While the last decade has brought considerable progress for patients with DMD, substantial unmet need remains. Several ...

Riding recent momentum in the Duchenne muscular dystrophy space, Capricor Therapeutics, Wave Life Sciences, Regenxbio and ...

Roche announces positive results from EMBARK phase III study of Elevidys in ambulatory individuals with DMD: Basel Tuesday, January 28, 2025, 11:00 Hrs [IST] Roche announced posit ...

Avidity is hoping to follow in the footsteps of Sarepta, which has launched a series of exon-skipping therapies for DMD, targeting exons 51, 53, and 45, that brought in around $1 billion in sales ...

Roche has reported positive results from the second year of the EMBARK Phase III trial of Elevidys (delandistrogene moxeparvovec), the first approv ...

TEMPE, Ariz., Jan. 16, 2025 /PRNewswire/ -- DMD Systems Recovery, LLC (DMD), a leader in Reuse First™ IT Asset Disposition (ITAD) services and a Certified B Corporation, has been ranked #27 ...

Prophylactic cardiac treatment in DMD patients is associated with a 54% lower hazard of death, highlighting its potential survival benefit. Only 27.7% of DMD patients received prophylactic cardiac ...

Dyne Therapeutics is a clinical stage biotech concern with just over $700 million of cash on its balance sheet. Learn more ...

DMD Ventures filed for Chapter 11 bankruptcy on Jan. 6. The company faces a $12 million lawsuit from a creditor. DMD partnered with Shaquille O'Neal for Big Chicken expansion. A Davie-based serial ...